# ILLUMINA, INC. (ILMN) — capital_raise/public_offering [pending]
Source: SEC API (secapi.ai) · situation sit_f0447d4a62311b253fdc · retrieved 2026-08-14T08:12:41.592Z

## Overview
Illumina, Inc. is a Delaware corporation that develops and provides laboratory analytical instruments and related services.

On August 10, 2026, Illumina, Inc. entered into an Underwriting Agreement with J.P. Morgan Securities LLC and Citigroup Global Markets Inc. (as representatives of the underwriters) for the issuance and sale of $300,000,000 aggregate principal amount of 4.950% notes due 2029. The offering is expected to close on August 17, 2026, subject to customary closing conditions. Illumina intends to use the net proceeds, together with cash on hand, to repay its 4.650% notes due September 9, 2026.

## Terms
- Counterparty: J.P. Morgan Securities LLC and Citigroup Global Markets Inc. · Deal value: $300.0M · Consideration: cash

## Key dates
- Announced 2026-08-12 · Expected close 2026-08-17

## Timeline
- 2026-08-12 · 8-K (0001193125-26-345802): 8-K - ILLUMINA, INC. — *Illumina, Inc. is a Delaware corporation that develops and provides laboratory analytical instruments and related services.* On August 10, 2026, Illumina, Inc. entered into an Underwriting Agreement with J.P. Morgan Securities LLC and Citigroup Global Markets Inc. (as representatives of the underwriters) for the issuance and sale of $300,000,000 aggregate principal amount of 4.950% notes due 2029. The offering is expected to close on August 17, 2026, subject to customary closing conditions. Illumina intends to use the net proceeds, together with cash on hand, to repay its 4.650% notes due September 9, 2026.
  https://www.sec.gov/Archives/edgar/data/1110803/0001193125-26-345802.txt

## Citations
- 0001193125-26-345802 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526345802